title: Successful treatment of graft-vs-host disease after a second liver transplant.
authors.affiliation: Liver Transplantation Unit, Hospital Argerich, Buenos Aires, Argentina. aziz@sat.org.ar
authors.forename: H
authors.initials: H
authors.lastname: Aziz
authors.forename: P
authors.initials: P
authors.lastname: Trigo
authors.forename: J
authors.initials: J
authors.lastname: Lendoire
authors.forename: G
authors.initials: G
authors.lastname: Bianco
authors.forename: J
authors.initials: J
authors.lastname: Saúl
authors.forename: G
authors.initials: G
authors.lastname: Braslavsky
authors.forename: M
authors.initials: M
authors.lastname: Kien
authors.forename: M
authors.initials: M
authors.lastname: Zylberman
authors.forename: G
authors.initials: G
authors.lastname: Cueto
authors.forename: O
authors.initials: O
authors.lastname: Imventarza
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000473:pathology / Q000628:therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006499:Hepatic Artery; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D009503:Neutropenia / Q000209:etiology / Q000628:therapy; D012086:Reoperation; D013927:Thrombosis
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016179:Granulocyte Colony-Stimulating Factor